The Medical insulin pump is a small and discrete device attached to the body that continuously delivers amounts of rapid or short-acting insulin through a catheter placed under the skin. These are computerized devices that have a similar functioning to the human pancreas and provide small doses of insulin during or after meal consumption. These are convenient, flexible and better alternative to insulin injections. They reduce the need for multiple insulin injections per day and give the user an increased ability to control blood glucose levels.
MARKET DYNAMICS
Rise in the geriatric population, increasing incidence rates of diabetes worldwide, growing awareness among the community and growing preference for non-invasive methods are expected to drive the market at a significant growth rate in the coming years. On the contrary, the absence of skilled professionals for proper insulin pump handling, the high price of insulin pumps and analogs, and skin infections are some of the restraining factors which could hinder the market.
MARKET SCOPE
The "Medical Insulin Pump Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of with detailed medical insulin pump market segmentation by type and end user. The medical insulin pump market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in medical insulin pump market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Medical insulin pump Market is segmented on the basis of type, application and end user. The market is segmented based on application as type I diabetes and type II diabetes. By type, insulin pump market has been segmented into disposable insulin pump and traditional insulin pump. The global insulin pumps market, based on end user, is segmented into hospital, clinics, home care, and laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the medical insulin pump market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The medical insulin pump market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting medical insulin pump market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the medical insulin pump market in these regions.
MARKET PLAYERS
The report covers key developments in the medical insulin pump market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from medical insulin pump market are anticipated to have lucrative growth opportunities in the future with the rising demand for medical insulin pump in the global market. Below mentioned is the list of few companies engaged in the medical insulin pump market.
The report also includes the profiles of key players in medical insulin pump market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- ?Medtronic, Inc
- Sanofi
- Tandem Diabetes Care, Inc.
- Insulet Corporation
- B. Braun Melsungen AG
- Becton, Dickinson and Company(BD)
- F.Hoffmann-La Roche Ltd.
- Abbott Laboratories
- SOOIL Developments Co., Ltd.
- Ypsomed AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.